Sidra Tree Foundation (STF) was established by New World Medical (NWM) to strategically focus its charitable efforts towards achieving equity in global eye care. NWM contributes 10% of its profits annually to seed STF, which operates independently. Foundation resources target results-oriented investments that empower eye care professionals and organizations striving to preserve and enhance vision in developing health care systems. We will strive to direct resources in an efficient and focused manner while evolving and expanding to better support the needs of partners and patients around the globe.

DIRECTORS

Bilal Khan is the President and Chief Executive Officer of New World Medical, a medical device firm based in Rancho Cucamonga, California.  He also serves on the Board of Directors of multiple for-profit and non-profit organizations.  Prior to joining New World Medical, he worked as an Actuary in Chicago, Los Angeles, and London, becoming a Fellow of the Society of Actuaries in 2008.

Mr. Khan holds a Bachelor of Business Administration in Actuarial Science from the University of Wisconsin-Madison, and a Master of Business Administration in Management from The Wharton School of the University of Pennsylvania, where he graduated with honors.

Malik Y. Kahook, MD is Professor of Ophthalmology and The Slater Family Endowed Chair in Ophthalmology at the University of Colorado School of Medicine. He is Vice Chair of Translational Research and serves as chief of the glaucoma service and co-director of the glaucoma fellowship at the University of Colorado Eye Center. Dr. Kahook has authored over 400 peer-reviewed manuscripts, abstracts, and book chapters, and is editor of Essentials of Glaucoma Surgery, MIGS: Advances in Glaucoma Surgery, the free online wiki www.keogt.com and the seminal textbook of glaucoma Chandler and Grant’s Glaucoma.

He was named New Inventor of the Year for the University of Colorado in 2009 and Inventor of the Year for 2010. Dr. Kahook has also received the American Glaucoma Society Innovator Award (2020), the American Academy of Ophthalmology Achievement Award in 2011, the American Academy of Ophthalmology Senior Achievement Award in 2017, the American Academy of Ophthalmology Secretariat Award (2014), the Ludwig Von Sallmann Clinician-Scientist Award (ARVO) in 2013 and was ranked second on the 40 under 40 Ophthalmology Power List (2015).  He was named to the top ten list of The Ophthalmologist Power 100 List in 2020.

Dr. Kahook has filed for over 150 patents, with over 50 granted patents licensed by companies including New World Medical, Alcon, Aurea Medical, and SpyGlass Pharma for development and commercialization. Several of his devices are currently in human trials or available globally for clinical use including the Kahook Dual Blade from New World Medical and the Harmoni modular intraocular lens system from ClarVista Medical which was acquired by Alcon.  Dr. Kahook serves as Chair of Orbis International’s Medical Advisory Committee and is a consultant to the Food and Drug Administration’s Ophthalmic Device Division.